Psychodiabetologie

 

 Buy Article Permissions and Reprints

Patienten mit Diabetes mellitus vom Typ 1 oder 2 benötigen relativ häufig eine psychotherapeutische oder psychopharmakologische Behandlung im Zusammenhang mit ihrer Erkrankung, z. B. wegen Problemen mit der Krankheitsbewältigung und/oder einer psychischen Komorbidität. Beide Anlässe sind oft verknüpft mit diabetes-spezifischen Problemen, aber auch mit Folge- oder Begleiterkrankungen.

Abstract

People affected by diabetes mellitus often have difficulties coping with their condition. This can be further worsened by psychological co-morbidities (e. g., depression or anxiety disorders). Both factors are associated with diabetes-specific problems (e. g., persistent hyperglycaemia, recurrent hypoglycaemia), but also with diabetes complications or comorbid somatic diseases. When psychotherapeutic or psychopharmacological treatment is indicated, it is essential to take into account the particularities of diabetes and the different types of diabetes. This review focuses on adults only and includes a brief description of the clinical features and therapeutic goals in diabetes mellitus. Critical diabetic symptoms that should result in specific interventions (yellow flags) as much as symptoms that require immediate intervention (red flags) are highlighted. Finally, psychological and behavioural factors as well as mental comorbidities that are relevant to the management of diabetes mellitus are discussed.

Publication History

Article published online:
30 March 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

• Literatur

• 1 Kulzer B, Albus C, Herpertz S. et al. Psychosoziales und Diabetes. Der Diabetologe 2020; 16: 144-160
  CrossrefPubMedGoogle Scholar
• 2 Petrak F, Herpertz S. Psychodiabetologie: Depression und Essstörungen bei Menschen mit Diabetes. Psychotherapeut 2019; 64: 489-508
  CrossrefPubMedGoogle Scholar
• 3 Abrahamian H, Kautzky-Willer A, Rießland-Seifert A. et al. Psychische Erkrankungen und Diabetes mellitus – update 2019. Wien Klin Wochenschr 2019; 131: 186-195
  PubMedGoogle Scholar
• 4 Deutsche Diabetes Gesellschaft S3-Leitlinie Therapie des Typ-1-Diabetes. 2. Auflage 2018 AWMF-Reg. Nr. 057-013
• 5 BÄK, KBV, AWMF Nationale Versorgungsleitlinie Therapie des Typ-2-Diabetes. 1. Auflage 2013 AWMF Reg. Nr. nvl-001g
• 6 Piepoli MF, Hoes AW, Agewall S. et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 2016; 37: 2315-2381
  CrossrefPubMedGoogle Scholar
• 7 Bieber C, Gschwendtner K, Müller N. et al. Partizipative Entscheidungsfindung (PEF) – Patient und Arzt als Team. Psychother Psych Med 2016; 66: 195-207
  Article in Thieme ConnectPubMedGoogle Scholar
• 8 Petrak F, Meier JJ, Albus C. et al. Motivation und Diabetes – Zeit für einen Paradigmenwechsel? Ein Positionspapier. Diabetologie und Stoffwechsel 2019; 14: 193-203
  Article in Thieme ConnectPubMedGoogle Scholar
• 9 Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care 2004; 27: 1218-1224
  CrossrefPubMedGoogle Scholar
• 10 Albus C, Geiser F. Was ist gesichert in der Therapie depressiver Komorbidität?. Der Internist 2019; 60: 1226-1234
  CrossrefPubMedGoogle Scholar
• 11 Petrak F, Baumeister H, Skinner TC. et al. Depression and diabetes: Treatment and health care delivery. The Lancet Diabetes & Endocrinology 2015; 3: 472-448
  CrossrefPubMedGoogle Scholar
• 12 Uchendu C, Blake H. Effectiveness of cognitive-behavioural therapy on glycaemic control and psychological outcomes in adults with diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials. Diabet Med 2017; 34: 328-339
  CrossrefPubMedGoogle Scholar
• 13 Petrak F. Ängste und Angststörungen bei Diabetes mellitus. In: Petrak F, Herpertz S , Hrsg. Psychodiabetologie. Heidelberg: Springer; 2013: 145–158
• 14 Petrak F, Stridde E, Leverkus F. et al. Development and validation of a new measure to evaluate psychological resistance to insulin treatment. Diabetes Care 2007; 30: 2199-2204
  CrossrefPubMedGoogle Scholar
• 15 Huang CJ, Hsieh HM, Chiu HC. et al. Impact of anxiety disorders on mortality for persons with diabetes: A national population-based cohort study. Psychosomatics 2017; 58: 266-273
  CrossrefPubMedGoogle Scholar
• 16 Pelizza L, Pupo S. Brittle diabetes: Psychopathology and personality. J Diabet Complicat 2016; 30: 1544-1547
  CrossrefPubMedGoogle Scholar
• 17 Kouidrat Y, Pizzoli D. Cosco et al. High prevalence of erectile dysfunction in diabetes: a systematic review and meta-analysis of 145 studies. Diabet Med 2017; 34: 1185-1192
  CrossrefPubMedGoogle Scholar
• 18 Pontiroli AE, Cortalezzi D, Morabito A. Female sexual dysfunction and diabetes: a systematic review and meta-analysis. J Sex Med 2013; 10: 1044-1051
  CrossrefPubMedGoogle Scholar
• 19 McCabe MP, Sharlip ID, Lewis R. et al. Risk factors for sexual dysfunction among women and men: A consenus statement from the forth international consultation on sexual medicine 2015. J Sex Med 2016; 13: 153-167
  CrossrefPubMedGoogle Scholar
• 20 DKPM, DGPM, DEGAM et al. S3 Leitlinie Funktionelle Körperbeschwerden. 2018; AWMF-Reg. Nr. 051-001